 There were several limitations in investigators previous study concerning intra-graft coagulation events in DGF. It was conducted as a part of a larger trial in renal transplantation and included only 30 patients in two study arms with different immunosuppressant regimens peri-operative basiliximab and conventional triple therapy. Therefore, a new study, with larger sample size and standardized immunosuppression is warranted. 